New therapeutic strategy for diabetic nephropathy

糖尿病肾病治疗新策略

基本信息

  • 批准号:
    21591148
  • 负责人:
  • 金额:
    $ 2.91万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2009
  • 资助国家:
    日本
  • 起止时间:
    2009 至 2011
  • 项目状态:
    已结题

项目摘要

Here, we hypothesized that mitochondria dysfunction due to aging-and diabetes-induced sirtuin 1(SIRT1) down regulation could result in renal inflammation, increased oxidative stress, and finally renal pathologies. Firstly, calorie restriction exerts anti-inflammatory effects and improves the dysregulation of autophagy through the restoration of SIRT1 in the aging kidneys, resulting in the amelioration of renal injuries. Secondly, resveratrol(RSV) ameliorates renal injury and enhanced mitochondrial biogenesis with Mn-SOD dysfunction in the kidney of db/db mice, through improvement of oxidative stress via normalization of Mn-SOD function and glucose-lipid metabolism via AMPK/SIRT1-independent pathway. Thirdly, calorie restriction exerts anti-inflammatory effects and improves the dysregulation of autophagy through the restoration of SIRT1 in the kidneys of WFRs, resulting in the amelioration of renal injuries in type 2 diabetes.
在这里,我们假设由于衰老和糖尿病诱导的Sirtuin 1(SIRT1)降低的线粒体功能障碍可能导致肾脏炎症,氧化应激增加,最后会导致肾脏病理。首先,卡路里限制会发挥抗炎作用,并通过恢复衰老肾脏中的SIRT1来改善自噬的失调,从而减轻肾脏损伤。其次,白藜芦醇(RSV)通过改善MN-SOD功能和葡萄糖 - 脂质函数和通过AMPK/SIRTSIRT1-依赖性的葡萄糖 - 依赖性的代谢性来改善氧化应激,从而改善DB/DB小鼠肾脏中Mn-SOD功能障碍的线粒体生物发生。第三,卡路里限制会产生抗炎作用,并通过恢复WFR肾脏的SIRT1来改善自噬的失调,从而改善2型糖尿病中肾脏损伤的改善。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sirt1による老化腎障害における虚血応答制御
Sirt1 对衰老肾损伤缺血反应的调节
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nagare T;Sakaue H;et al;Liang F;古家大祐
  • 通讯作者:
    古家大祐
Effectiveness of Calorie restriction on Ameliorating Diabetic Nephropathy possibly through its anti-inflammatory action
热量限制可能通过其抗炎作用改善糖尿病肾病的有效性
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    小田邊修一;橋永俊彦;原暁紅;福谷知香;大木剛;柿野聡美;和田暢彦;栗田弥生;中山ひとみ;田尻祐司;下川功;山田研太郎;KOYA D
  • 通讯作者:
    KOYA D
SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications.
Reversal of redox-dependent inhibition of diacylglycerol kinase by antioxidants in mesangial cells exposed to high glucose
  • DOI:
    10.3892/mmr.2011.524
  • 发表时间:
    2011-09-01
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Atsumi, Hisanari;Kitada, Munehiro;Koya, Daisuke
  • 通讯作者:
    Koya, Daisuke
Emerging role of autophagy in kidney function, diseases and aging
  • DOI:
    10.4161/auto.19821
  • 发表时间:
    2012-07-01
  • 期刊:
  • 影响因子:
    13.3
  • 作者:
    Huber, Tobias B.;Edelstein, Charles L.;Dong, Zheng
  • 通讯作者:
    Dong, Zheng
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOYA Daisuke其他文献

KOYA Daisuke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOYA Daisuke', 18)}}的其他基金

Endothelial autophagy deficiency induces interleukin 6-dependent endothelial mesenchymal transition and organ fibrosis
内皮自噬缺陷诱导白细胞介素6依赖性内皮间质转化和器官纤维化
  • 批准号:
    16K15472
  • 财政年份:
    2016
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
New therapeutic strategy for diabetic nephropathy via autophagy regulation
通过自噬调节治疗糖尿病肾病的新策略
  • 批准号:
    25670414
  • 财政年份:
    2013
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Alteration in nutrient sensing and metabolic diseases
营养感应和代谢疾病的改变
  • 批准号:
    25282028
  • 财政年份:
    2013
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The role of SIRT1 in mediating renal cells apoptosis and its therapeutic perspective
SIRT1介导肾细胞凋亡的作用及其治疗前景
  • 批准号:
    17590925
  • 财政年份:
    2005
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of N-acetyl seryl-aspartyl-lysyl-proline on renal insufficiency and mesangial matrix expansion in diabetic db/db mice
N-乙酰丝氨酰-天冬氨酰-赖氨酰-脯氨酸对糖尿病 db/db 小鼠肾功能不全和系膜基质扩张的影响
  • 批准号:
    15590936
  • 财政年份:
    2003
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular Mechanism in the development of diabetic nephropathy-the role of diacylglycerol kinase in regulating protein kinase C activity-
糖尿病肾病发生发展的分子机制-二酰甘油激酶在调节蛋白激酶C活性中的作用-
  • 批准号:
    12671109
  • 财政年份:
    2000
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ROLE OF DIABETES-INDUCED GLOMERULAR PKC-MAPK ACTIVATION ON DIABETIC GLOMERULOSCLEROSIS
糖尿病引起的肾小球 PKC-MAPK 激活对糖尿病肾小球硬化的作用
  • 批准号:
    10670995
  • 财政年份:
    1998
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

糖代謝異常によって誘導されるPKCβ活性化の妊娠高血圧腎症発症と増悪における意義
糖代谢异常诱导的PKCβ激活在子痫前期发病和恶化中的意义
  • 批准号:
    19K18697
  • 财政年份:
    2019
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of metabolic alterations in diabetic kidney disease and development of new treatment strategy by amelioration of metabolic alterations
分析糖尿病肾病的代谢改变并通过改善代谢改变制定新的治疗策略
  • 批准号:
    19K17717
  • 财政年份:
    2019
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Clinical significance and mechanism of serum sulfatide abnormalities in chronic kidney disease
慢性肾脏病血清硫苷脂异常的临床意义及机制
  • 批准号:
    18K08204
  • 财政年份:
    2018
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Screening of drug target proteins for diabetic nephropathy by identification of ChREBP complex from renal mesangial cells
通过鉴定肾系膜细胞 ChREBP 复合物筛选糖尿病肾病药物靶蛋白
  • 批准号:
    16K08606
  • 财政年份:
    2016
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of renal protein O-GlcNAcylation
肾蛋白 O-GlcNAc 酰化的作用
  • 批准号:
    16K09612
  • 财政年份:
    2016
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了